Quince Therapeutics Inc (QNCX)

Currency in USD
1.680
-0.120(-6.67%)
Closed·
After Hours
1.6800.000(0.00%)
·
QNCX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 14 days
Fair Value
Day's Range
1.6501.870
52 wk Range
0.5122.450
Key Statistics
Prev. Close
1.8
Open
1.85
Day's Range
1.65-1.87
52 wk Range
0.512-2.45
Volume
251.94K
Average Volume (3m)
380.07K
1-Year Change
129.1%
Book Value / Share
0.42
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
QNCX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.400
Upside
+340.48%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Quince Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Quince Therapeutics Inc Company Profile

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient’s own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Compare QNCX to Peers and Sector

Metrics to compare
QNCX
Peers
Sector
Relationship
P/E Ratio
−1.3x−5.4x−0.5x
PEG Ratio
0.020.020.00
Price/Book
4.1x3.6x2.6x
Price / LTM Sales
-9.4x3.2x
Upside (Analyst Target)
384.8%133.4%41.2%
Fair Value Upside
Unlock5.8%6.2%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.400
(+340.48% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.34 / -0.19
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

QNCX Income Statement

People Also Watch

1.820
ONDS
-9.00%
1.510
HOVR
-8.48%
108.74
CRWV
-1.40%
2.350
VOR
-2.89%
6.620
BBAI
-7.41%

FAQ

What Stock Exchange Does Quince Therapeutics Trade On?

Quince Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Quince Therapeutics?

The stock symbol for Quince Therapeutics is "QNCX."

What Is the Quince Therapeutics Market Cap?

As of today, Quince Therapeutics market cap is 75.25M.

What Is Quince Therapeutics's Earnings Per Share (TTM)?

The Quince Therapeutics EPS (TTM) is -1.40.

When Is the Next Quince Therapeutics Earnings Date?

Quince Therapeutics will release its next earnings report on 11 Aug 2025.

From a Technical Analysis Perspective, Is QNCX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Quince Therapeutics Stock Split?

Quince Therapeutics has split 0 times.

How Many Employees Does Quince Therapeutics Have?

Quince Therapeutics has 36 employees.

What is the current trading status of Quince Therapeutics (QNCX)?

As of 29 Jul 2025, Quince Therapeutics (QNCX) is trading at a price of 1.68, with a previous close of 1.80. The stock has fluctuated within a day range of 1.65 to 1.87, while its 52-week range spans from 0.51 to 2.45.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.